Description: In this session a panel of industry experts from the life insurance industry will examine the modeling challenges created by increased investment in more esoteric assets.

Description: How do we take a Minimum Viable Products (MVP) approach to launch new insurance products? Join this moderated discussion and focus on three key development aspects: Distribution, Systems, and the design and pricing of the Insurance product itself. Come discuss reasons to choose an MVP approach and how it solves many of the product launch challenges.

Description: At the end of December 2020, Congress enacted the Consolidated Appropriates Act, 2021, which included revisions to Section 7702. Effective for policies issued after December 31, 2020, the fixed 4% and 6% minimum annual effective rates under these tests were changed to refer to a market-based rate called the “insurance interest rate”. For contracts issued in 2021, the insurance rate was set to 2% - defined as the lower of the Section 7702 applicable federal interest rate based on the 60-month period ending December 2019 (2%) and the Section 7702 valuation interest rate in effect for 2020 (3.5%). This reduction in the rates used for compliance testing required significant product, operational, and technology changes for companies to reach product compliance. After 2021, the insurance interest rate is redetermined annually with a minimum change floor.

Description: How do you go about designing a new product? Behavioral Science is an often overlooked tool in enhancing product design and using a Discrete Choice Experiment (DCE) can give you insights to customer preferences and their willingness to pay for features. The result of this work is a product explicitly designed with your customers and market in mind.

Description: Join us for an exciting session as Actuarial Innovation & Technology Strategic Research from the SOA's Research Institute unveils two recently published research reports: ""Unveiling the Life Insurers' Actuarial Transformation Journey and the Impact of Analytics"" and ""Exploring Revolutionary Advances in Underwriting: An Initial Assessment of Epigenetics, Medical Tests, and Wearables"". In the first report, we delve into the evolving landscape of life insurers' Actuarial Transformation efforts, shedding light on their future prospects and emphasizing emerging Advanced Analytics techniques. The second report serves as the inaugural installment of a series dedicated to identifying promising innovations for underwriters and actuaries, and it promises to alert the SOA to the latest developments. During this session, our presenters will provide an insightful overview of the key findings and key takeaways from both research reports. By the end of the session, attendees will gain a deeper understanding and appreciation for the invaluable research conducted in these areas.

Description: Come discuss modeling costs and its governance, as well as introduce some platforms for more granular asset modeling.

Description: Gather with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, pension, investment, product strategy, and more.

Description: How can generative artificial intelligence (AI) be leveraged to transform and modernize life insurance? Gain an overview of AI and some of their current use cases in the industry, including the latest trends in the market. Next, you will learn about the current challenges companies face, including costly underwriting procedures, customer acquisition and retention, and complicated application processes. Finally, explore how generative AI can help address these challenges, improve customer experience and help streamline processes to free up more time for higher-level business insights and other company initiatives.

Description: ReMark's Global Consumer Study delivers 10 key insights to empower customers. Insurers can design products that meet customers' needs and enhance client experiences and add significant value to their business. At the same time with new products being launched seemingly continuously, it is important to take a step back and assess risk throughout the product management cycle.